FGA: Fibrinogen Alpha Chain
Key coagulation factor and acute phase protein
Gene Information Card
| Symbol | FGA |
|---|---|
| Full Name | Fibrinogen Alpha Chain |
| Gene Type | protein-coding |
| Chromosomal Location | 4q31.3 |
| NCBI Gene ID | 2243 ncbi.nlm.nih.gov/gene/2243 |
| Ensembl ID | ENSG00000171560 |
| UniProt ID | P02671 |
| OMIM ID | 134820 |
| HGNC ID | 3661 |
| Aliases | FGA, fibrinogen A alpha chain, fibrinogen alpha polypeptide |
Description
The FGA gene encodes the alpha chain of fibrinogen, a plasma glycoprotein essential for blood coagulation. Fibrinogen is a hexamer composed of two sets of three chains (Aα, Bβ, γ) linked by disulfide bonds. The alpha chain contains a central coiled-coil region and a C-terminal globular domain. During coagulation, thrombin cleaves fibrinopeptide A from the Aα chain, initiating fibrin polymerization. FGA mutations can lead to quantitative (afibrinogenemia, hypofibrinogenemia) or qualitative (dysfibrinogenemia) fibrinogen deficiencies, associated with bleeding or thrombosis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Congenital Afibrinogenemia | Complete absence of fibrinogen due to homozygous or compound heterozygous FGA mutations; leads to severe bleeding tendency | ClinVar, OMIM #202400 |
| Congenital Hypofibrinogenemia | Reduced fibrinogen levels due to heterozygous FGA mutations; mild to moderate bleeding risk | ClinVar, OMIM #134820 |
| Dysfibrinogenemia | Qualitative defect in fibrinogen function; can cause bleeding or thrombosis depending on mutation site | ClinVar, OMIM #134820 |
| Thrombosis | Certain FGA mutations (e.g., Fibrinogen Dusart) impair fibrinolysis and increase thrombotic risk | ClinVar, OMIM #134820 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 1000.0 | High |
| Plasma | N/A | High (secreted) |
| Kidney | 10.0 | Low |
| Lung | 5.0 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 1200.0 | Hepatocyte cell line, high expression |
| Huh-7 | 1100.0 | Hepatocyte cell line, high expression |
| HEK293 | 2.0 | Very low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.104G>A (p.Arg35His) | Missense | Rare | Dysfibrinogenemia; impaired fibrinopeptide A release |
| c.510C>T (p.Arg170Cys) | Missense | Rare | Dysfibrinogenemia; abnormal polymerization |
| c.1A>G (p.Met1Val) | Start loss | Rare | Afibrinogenemia; no protein production |
| c.1195delC (p.Gln399Serfs*2) | Frameshift | Rare | Afibrinogenemia; premature truncation |
Mutation functional classification
Loss of Function (LOF)
Nonsense, frameshift, and splice-site mutations causing afibrinogenemia or hypofibrinogenemia (e.g., c.1195delC, c.1A>G).
Gain of Function (GOF)
Not typically described; some missense mutations may enhance thrombogenicity indirectly.
Dominant Negative (DN)
Missense mutations in dysfibrinogenemia (e.g., p.Arg35His) can interfere with normal fibrinogen assembly and function.
View complete mutation data:
Gene Ontology (GO)
Pathways
• KEGG hsa04610 - Complement and coagulation cascades
• Reactome R-HSA-140877 - Formation of Fibrin Clot (Clotting Cascade)
• Reactome R-HSA-114608 - Platelet degranulation
Protein Summary
Fibrinogen alpha chain (UniProt P02671) is a 866-amino acid protein (including signal peptide) with a molecular weight of ~95 kDa. It contains a coiled-coil region and a C-terminal fibrinogen-related domain (FReD). The alpha chain is heavily glycosylated and contains multiple phosphorylation sites. It is synthesized primarily in hepatocytes and secreted into plasma. Upon thrombin cleavage, it releases fibrinopeptide A and participates in fibrin clot formation. The alpha chain also contains binding sites for factor XIIIa, which crosslinks fibrin polymers, and for integrin receptors on platelets.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FGA Knockout HEK293 Cell Line | EDJ-KQ2280 | Human | 2243 | Details Get a Quote |
| ARFGAP3 Knockout HEK293 Cell Line | EDJ-KQ8505 | Human | 26286 | Details Get a Quote |
| ARFGAP2 Knockout HEK293 Cell Line | EDJ-KQ9297 | Human | 84364 | Details Get a Quote |
| ARFGAP1 Knockout HEK293 Cell Line | EDJ-KQ12403 | Human | 55738 | Details Get a Quote |
| ARFGAP2 Knockout A-549 Cell Line | EDJ-KQ37142 | Human | 84364 | Details Get a Quote |
| ARFGAP2 Knockout HCT 116 Cell Line | EDJ-KQ37144 | Human | 84364 | Details Get a Quote |
| ARFGAP2 Knockout HeLa Cell Line | EDJ-KQ37145 | Human | 84364 | Details Get a Quote |
| ARFGAP1 Knockout A-549 Cell Line | EDJ-KQ41293 | Human | 55738 | Details Get a Quote |
| ARFGAP1 Knockout HCT 116 Cell Line | EDJ-KQ41294 | Human | 55738 | Details Get a Quote |
| ARFGAP1 Knockout HeLa Cell Line | EDJ-KQ41295 | Human | 55738 | Details Get a Quote |
| FGA Knockout A-549 Cell Line | EDJ-KQ21296 | Human | 2243 | Details Get a Quote |
| ARFGAP3 Knockout A-549 Cell Line | EDJ-KQ34630 | Human | 26286 | Details Get a Quote |
| ARFGAP3 Knockout HCT 116 Cell Line | EDJ-KQ34631 | Human | 26286 | Details Get a Quote |
| ARFGAP3 Knockout HeLa Cell Line | EDJ-KQ34632 | Human | 26286 | Details Get a Quote |
| FGA Knockout Hep-G2 Cell Line | EDJ-KZ250 | Human | 2243 | Details Get a Quote |
Displaying Records 1 To 15 Of 17 Records